This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring
Adults aged 19 years or older
Patients admitted to Chonnam National University Hospital who require ECG monitoring
Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy
Individuals who are unable to provide consent themselves or through a legally designated representative
Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment
Single group
ECG monitoring by telemetry device and patch-type ECG monitor at the same time
DeviceThe patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.
The number of total QRS complex
Number of total QRS complex is compared based on the data obtained simultaneously from two devices.
The rate of signal loss
Rate of signal loss is compared based on the data obtained simultaneously from two devices.
Average heart rate
Average heart rate is compared based on the data obtained simultaneously from two devices.
The number of arrhythmia and technical alarm
Number of arrhythmia and technical alarm is compared based on the data obtained simultaneously from two devices.
Results of satisfaction survey
Satisfaction survey responses from the medical staff
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
